Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
UT-15C add-on to oral monotherapy in pulmonary arterial hypertension
2012-000097-26Phase 3Completed
- Sponsor
- United Therapeutics Corporation
- Start
- Aug 2012
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in pulmonary arterial hypertension (PAH) comparing Treprostinil diethanolamine + background oral monotherapy with Placebo + background oral monotherapy (2 arms). Primary endpoint: Time to first adjudicated clinical worsening event. Started Aug 2012; status: completed.
02
Drugs
treprostinil
03
Conditions
pulmonary arterial hypertension (PAH)
Beyond the preview
Go deeper on 2012-000097-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-000097-26.